Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-xL

Carcinogenesis

Volumn 27, Issue 6, 2006, Pages 1169-1179

  Méndez, Olga ^a   Martín, Berta ^a   Sanz, Rebeca ^a   Aragüés, Ramón ^b   Moreno, Victor ^c   Oliva, Baldo ^b   Stresing, Verena ^a   Sierra, Angels ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; COMPLEMENTARY DNA; PROTEIN BCL XL; PROTEIN KINASE; TATA BINDING PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; ELECTRON TRANSPORT; FILTER; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; MICROENVIRONMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 33745608734     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi363     Document Type: Article

References (54)

1. Chambers, A.F., Naumov, G.N., Varghese, H.J., Nadkarni, K.V., MacDonald, I.C. and Groom, A.C. (2001) Critical steps in hematogenous metastasis: an overview. Surg. Oncol. Clin. N Am., 10, 243-255, vii.
2. Phillips, K.K., White, A.E., Hicks, D.J., Welch, D.R., Barrett, J.C., Wei, L.L. and Weissman, B.E. (1998) Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Mol. Carcinog., 21, 111-120.
3. Russo, J., Yang, X., Hu, Y.F. et al. (1998) Biological and molecular basis of human breast cancer. Front Biosci., 3, D944-D960.
4. Bai, M., Agnantis, N.J., Kamina, S., Demou, A., Zagorianakou, P., Katsaraki, A. and Kanavaros, P. (2001) In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res., 3, 276-283.
5. Nathanson, K.L., Wooster, R., Weber, B.L. and Nathanson, K.N. (2001) Breast cancer genetics: What we know and what we need. Nat. Med., 7, 552-556.
6. Cheng, J.D. and Weiner, L.M. (2003) Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9, 1639-1647, 1590-1595.
7. Fidler, I.J. and Kripke, M.L, (2003) Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat. Genet., 34, 23, author reply 25.
8. Rubin, H. (2001) Selected cell and selective microenvironment in neoplastic development. Cancer Res., 61, 799-807.
9. Vogelstein, B. and Kinzler, K.W. (2004) Cancer genes and the pathways they control. Nat. Med., 10, 789-799.
10. Fidler, I.J. (2003) The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat. Rev. Cancer, 3, 453-458.
11. Breivik, J. (2001) Don't stop for repairs in a war zone: Darwinian evolution unites genes and environment in cancer development. Proc. Natl Acad. Sci. USA, 98, 5379-5381.
12. Bernards, R. and Weinberg, R.A. (2002) A progression puzzle. Nature, 418, 823.
13. Cahill, D.P., Kinzler, K.W,, Vogelstein, B. and Lengauer, C. (1999) Genetic instability and Darwinian selection in tumours. Trends Cell Biol., 9, M57-M60.
14. Perucho, M. (2003) Tumors with microsatellite instability: Many mutations, targets and paradoxes. Oncogene, 22, 2223-2225.
15. Zhivotovsky, B. and Kroemer, G. (2004) Apoptosis and genomic instability. Nat. Rev. Mol. Cell Biol., 5, 752-762.
16. Johnstone, R.W., Ruefli, A.A. and Lowe,S.W. (2002) Apoptosis: A link between cancer genetics and chemotherapy. Cell, 108, 153-164.
17. McConkey, D.J., Greene, G. and Pettaway, C.A. (1996) Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res., 56, 5594-5599.
18. Fernandez,Y., Espana,L., Manas,S., Fabra,A. and Sierra,A. (2000) Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ., 7, 350-359.
19. Gu, B., Espana, L., Mendez, O., Torregrosa, A. and Sierra, A. (2004) Organ-selective chemoresistance in metastasis from human breast cancer cells: Inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus. Carcinogenesis, 25, 2293-2301.
20. L-mediated changes in metabolic pathways of breast cancer cells from survival in the blood stream to organ-specific metastasis. Am. J. Pathol., 167, 1125-1137.
21. Rubio, N., Espana, L., Fernandez, Y., Blanco, J. and Sierra, A. (2001) Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: A role in dormancy and organospecificity. Lab. Invest., 81, 725-734.
22. Espana, L., Fernandez, Y., Rubio, N., Torregrosa, A., Blanco,J. and Sierra,A. (2004) Overexpression of Bcl-x(L) in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res. Treat., 87, 33-44.
23. Dopazo, J., Zanders, E., Dragoni, I., Amphlett, G. and Falciani, F. (2001) Methods and approaches in the analysis of gene expression data. J. Immunol. Methods, 250, 93-112.
24. Walker, J. and Rigley, K. (2000) Gene expression profiling in human peripheral blood mononuclear cells using high-density filter-based cDNA microarrays. J. Immunol. Methods, 239, 167-179.
25. Pfaffl, M.W. (2001) Anew mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
26. von Mering, C., Huynen, M., Jaeggi, D., Schmidt, S., Bork, P. and Snel, B. (2003) STRING: A database of predicted functional associations between proteins. Nucleic Acids Res., 31, 258-261.
27. Enright, A.J., Hiopoulos, I., Kyrpides, N.C. and Ouzounis, C.A. (1999) Protein interaction maps for complete genomes based on gene fusion events. Nature, 402, 86-90.
28. Pellegrini, M., Marcotte, E.M., Thompson, M.J., Eisenberg,D. and Yeates, T.O. (1999) Assigning protein functions by comparative genome analysis: protein phylogenetic profiles. Proc. Natl Acad. Sci. USA, 96, 4285-4288.
29. Yu, H., Luscombe, N.M., Lu, H.X., Zhu, X., Xia, Y., Han, J.D., Bertin, N., Chung, S., Vidal, M. and Gerstein, M. (2004) Annotation transfer between genomes: Protein-protein interologs and protein-DNA regulogs. Genome Res., 14, 1107-1118.
30. Fernandez, Y., Gu, B., Martinez, A., Torregrosa, A. and Sierra, A. (2002) Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state. Int. J. Cancer, 101, 317-326.
31. Pereira, L.A., Klejman, M.P. and Timmers, H.T. (2003) Roles for BTAF1 and Mot1p in dynamics of TATA-binding protein and regulation of RNA polymerase II transcription. Gene, 315, 1-13.
32. Andrau, J.C., Van Oevelen, C.J., Van Teeffelen, H.A., Weil, P.A., Holstege, F.C, and Timmers, H.T. (2002) Mot1p is essential for TBP recruitment to selected promoters during in vivo gene activation. EMBO J., 21, 5173-5183.
33. Hochheimer, A. and Tjian, R. (2003) Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. Genes Dev., 17, 1309-1320.
34. Johnson, S.A., Dubeau, L., Kawalek, M., Dervan, A., Schonthal, A.H., Dang, C.V. and Johnson, D.L. (2003) Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. Mol. Cell Biol., 23, 3043-3051.
35. Chicca, J.J., II, Auble, D.T. and Pugh, B.F. (1998) Cloning and biochemical characterization of TAF-172, a human homolog of yeast Mot1. Mol. Cell Biol., 18, 1701-1710.
36. Dasgupta, A., Darst, R.P., Martin, K.J., Afshari, C.A. and Auble, D.T. (2002) Mot1 activates and represses transcription by direct, ATPase-dependent mechanisms. Proc. Natl Acad. Sci. USA, 99, 2666-2671.
37. Li, C., Fox, C.J., Master, S.R., Bindokas, V.P., Chodosh, L.A. and Thompson, C.B. (2002) Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Proc. Natl Acad. Sci. USA, 99, 9830-9835.
38. Vander Heiden, M.G., Choy, J.S., VanderWeele, D.J., Brace, J.L., Harris, M.H., Bauer, D.E., Prange, B., Kron, S.J., Thompson, C.B. and Rudin, C.M. (2002) Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism. J. Biol. Chem., 277, 44870-44886.
39. Yanagidani, A., Matsuoka, M., Yokoro, K., Tanaka,H. and Numoto, M. (2000) Identification of human autoantibodies to the transcriptional repressor ZF5. J. Autoimmun., 15, 75-80.
40. Numoto, M., Yokoro, K. and Koshi, J. (1999) ZF5, which is a Kruppel-type transcriptional repressor, requires the zinc finger domain for self-association. Biochem. Biophys. Res. Commun., 256, 573-578,
41. Watson, P.H., Safneck, J.R., Le, K., Dubik, D. and Shiu, R.P. (1993) Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J. Natl Cancer Inst., 85, 902-907.
42. Sierra, A., Castellsague, X., Escobedo, A., Moreno, A., Drudis, T. and Fabra, A. (1999) Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas. Breast Cancer Res. Treat., 54, 39-45.
43. Perou, C.M., Jeffrey, S.S., van de Rijn, M. et al. (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA, 96, 9212-9217.
44. Ramaswamy, S., Ross, K.N., Lander, E.S. and Golub,T.R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet., 33, 49-54.
45. van't Veer, L.J., Dai, H., van de Vijver, M.J. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
46. Kang, Y., Siegel, P.M., Shu, W., Drobnjak, M., Kakonen, S.M., Cordon-Cardo, C., Guise, T.A. and Massague, J. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3, 537-549.
47. Minn, A., Gupta, G.P., Siegel, P.M., Bos, P.D., Shu, W., Giri, D.D., Viale, A., Olshen, A.B., Gerald, W.L. and Massagué, J. (2005) Genes that mediate breast cancer metastais to lung. Nature, 436, 518-524.
48. Schmidt-Kittler, O., Ragg, T., Daskalakis, A. et al. (2003) From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc. Natl Acad Sci. USA, 100, 7737-7742.
49. Montel, V., Huang, T.Y., Mose, E., Pestonjamasp, K. and Tarin, D. (2005) Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am. J. Pathol., 166, 1565-1579.
50. Liotta, L.A. (2001) An attractive force in metastasis. Nature, 410, 24-25.
51. Gray, J.W. (2003) Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell, 4, 4-6.
52. Su, A.I., Welsh, J.B., Sapinoso, L.M. et at. (2001) Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res., 61, 7388-7393.
53. Sorlie, T., Perou, C.M., Tibshirani, R. et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA, 98, 10869-10874.
54. Ross, D.T., Scherf, U., Eisen, M.B. et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet., 24, 227-235.